Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection DOI Open Access
F. Cannata, Kamil Stankowski, Michele Galasso

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(20), P. 6144 - 6144

Published: Oct. 15, 2024

The growing awareness of tricuspid regurgitation (TR) and the fast-expanding array devices aiming to percutaneously repair or replace valve have underscored central role multi-modality imaging in comprehensively assessing anatomical functional characteristics TR. Accurate phenotyping TR, right heart, pulmonary vasculature via echocardiography, computed tomography, and, occasionally, cardiovascular magnetic resonance heart catheterization is deemed crucial choosing most suitable treatment strategy for each patient achieving procedural success. In first part present review, key factors selection will be discussed. ensuing sections, an overview commonly used, commercially available systems transcatheter repair/replacement presented, along with their respective criteria information on intraprocedural guidance; these are edge-to-edge repair, orthotopic heterotopic replacement, valve-in-valve procedures.

Language: Английский

Transcatheter Tricuspid Valve Replacement DOI Creative Commons

Jörg Hausleiter,

Lukas Stolz, Philipp Lurz

et al.

Journal of the American College of Cardiology, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Citations

5
Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach DOI

Maurizio Tusa,

Sara Amicone

International Journal of Cardiology, Journal Year: 2025, Volume and Issue: unknown, P. 133007 - 133007

Published: Jan. 1, 2025

Language: Английский

Citations

0
Atrial Functional Tricuspid Regurgitation (AFTR) Is Associated with Better Outcome After Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) Compared to Ventricular FTR (VFTR) DOI Open Access

Jinny Karin Scheffler,

Juliane Ott,

M. Jane Landes

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(3), P. 794 - 794

Published: Jan. 25, 2025

Background: Transcatheter tricuspid edge-to-edge repair (T-TEER) is widely used to treat atrial (AFTR) and ventricular (VFTR) functional regurgitation (FTR). Methods: The outcome of 136 patients treated with T-TEER for severe AFTR or VFTR was analyzed using a composite endpoint all-cause death rehospitalization decompensated heart failure. defined as TR in the context left ejection fraction ≥50%, right fractional area change (RVFAC) ≥ 35% sPAP ≤ 50 mmHg. Results: Patients (N = 109) 27, 19.9%) were both elderly (82.0 {IQR: 74.5–84.5} vs. 82.0 75.0–84.0} years, p 0.98) had similar interventional risk according EuroScore II (6.1 {4.0–9.8} 4.7 {3.6–9.6} %, 0.3). Atrial fibrillation equally frequent groups (89.9 88.9%, 0.88). significantly more often female (56.0 77.8%, 0.04) lower NT-proBNP (3600.0 {1706.0–6302.0} 1988.0 {1034.8–3723.3} pg/mL, < 0.01). While RVFAC (29.5 ± 8.6 42.1 4.3%, 0.01) LVEF (48.5 12.3 58.6 8.0%, expectedly VFTR, dilation (RA volume: 126.7 56.5 127.6 74.2 mL, 0.99) similar. Successful reduction 2 degrees (96.3 92.6%, 0.34) observed groups, residual (94.5 96.3%, 1.0). incidence 1-year higher (34.3 12.0%) (log-rank 0.02). inversely associated (HR: 0.21, 95% CI: 0.06–0.7, multivariate Cox regression. Conclusions: Despite effective through T-TEER, better AFTR.

Language: Английский

Citations

0
One-Year Recurrent Tricuspid Regurgitation after Successful Transcatheter Edge to Edge Repair: the TRI-SPA Registry DOI
Julio Echarte‐Morales, Pedro Cepas‐Guillén, Dabit Arzamendi

et al.

The American Journal of Cardiology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

0
Efficacy and Safety of Cardioband in Patients with Tricuspid Regurgitation: Systematic Review and Meta-Analysis of Single-Arm Trials and Observational Studies DOI Open Access
Eugenia Piragine, Sara Veneziano, Sabrina Trippoli

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(21), P. 6393 - 6393

Published: Oct. 25, 2024

: The incidence and prevalence of tricuspid regurgitation (TR) are increasing worldwide. "Traditional" drug therapy with diuretics is often ineffective the identification new strategies, including non-pharmacological ones, an urgent need. aim this study was to summarize results on efficacy safety Cardioband, one few approved transcatheter valve repair systems, in patients TR.

Language: Английский

Citations

3
Make Right Heart Remodeling in Secondary Tricuspid Regurgitation as Simple as Possible, But Not Simpler DOI
Luigi P. Badano, Denisa Muraru

JACC. Cardiovascular imaging, Journal Year: 2024, Volume and Issue: 17(6), P. 607 - 609

Published: March 20, 2024

Language: Английский

Citations

2
Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry DOI
Julio Echarte‐Morales, Andrea Scotti, Guillaume Bonnet

et al.

International Journal of Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 132889 - 132889

Published: Dec. 1, 2024

Language: Английский

Citations

2
Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence DOI Creative Commons
Yasser Sammour, Muhammad Faraz Anwaar, Francisco J. Cabral-Amador

et al.

Heart International, Journal Year: 2024, Volume and Issue: 18(2), P. 24 - 36

Published: Dec. 19, 2024

Tricuspid regurgitation (TR) is a common valvular heart disease that associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities risks, especially for high-risk patients, in-hospital mortality rates of ˜9%. This resulted in the undertreatment many patients TR, creating substantial unmet need. has stimulated development transcatheter techniques, such as tricuspid valve replacement, edge-to-edge repair, annuloplasty, caval implantation others, which offer less-i nvasive alternatives promising early results sustained benefits. review provides contemporary outlook on different interventions severe TR assesses existing clinical data regarding safety effectiveness these devices rapidly expanding space.

Language: Английский

Citations

1
Tricuspid Regurgitation DOI
Jeroen J. Bax,

Y. Chandrashekhar

JACC. Cardiovascular imaging, Journal Year: 2024, Volume and Issue: 17(6), P. 713 - 714

Published: June 1, 2024

Citations

0
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection DOI Open Access
F. Cannata, Kamil Stankowski, Michele Galasso

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(20), P. 6144 - 6144

Published: Oct. 15, 2024

The growing awareness of tricuspid regurgitation (TR) and the fast-expanding array devices aiming to percutaneously repair or replace valve have underscored central role multi-modality imaging in comprehensively assessing anatomical functional characteristics TR. Accurate phenotyping TR, right heart, pulmonary vasculature via echocardiography, computed tomography, and, occasionally, cardiovascular magnetic resonance heart catheterization is deemed crucial choosing most suitable treatment strategy for each patient achieving procedural success. In first part present review, key factors selection will be discussed. ensuing sections, an overview commonly used, commercially available systems transcatheter repair/replacement presented, along with their respective criteria information on intraprocedural guidance; these are edge-to-edge repair, orthotopic heterotopic replacement, valve-in-valve procedures.

Language: Английский

Citations

0